Cite Filings / KROS / 0000902664-25-003804

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Keros Therapeutics, Inc. Filed 2025-08-21 Acc 0000902664-25-003804

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-10-15 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-28 8-K Regulation FD disclosure
2025-08-21 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-20 8-K Other events
2025-08-15 3 Initial Statement of Ownership
2025-08-15 3 Initial Statement of Ownership
2025-05-12 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…